Investing Profile

Andy Tran

VCInvestor
Principal at Matrix Capital Management Company, L.P.
crunchbase.com/organization/m...San Francisco Bay Area
Photo of Andy Tran, Principal at Matrix Capital Management Company, L.P.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Morgan Stanley Network
235 CONNECTIONS
Andreessen Horowitz Network
106 CONNECTIONS
Genentech Network
30 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
cb
$100K - $10.0M
$1M
2
CompanyStageDateRound SizeTotal Raised
Maze Therapeutics
Series UnknownJan 2022$190M
$800M
Co-investors: Jonathan Lim (SignalFire), Brendan Bulik-Sullivan (GV (Google Ventures)), Anthony Philippakis (GV (Google Ventures)), James W. Brush (Frazier Healthcare Partners), Charles Homcy (Third Rock Ventures), Jonathan Lim (ARCH Venture Partners)
GentiBio
Series AAug 2021$160M
$160M
Investing in biotech, healthcare, and companies at the cross section of bio and AI/ML.
Board Observer and Investor ReCode Therapeutics2022 - Present
Board Director and Lead Investor Maze Therapeutics2022 - Present
Board Director and Lead Investor GentiBio2021 - Present
Principal Matrix Capital Management Company, L.P.2021 - Present
Investment Partner Andreessen Horowitz2018 - 2021
Investor and Board Observer Scribe Therapeutics2018 - 2021
Board Observer Asimov2018 - 2021
Investor insitro2018 - 2021
Investor EQRx2018 - 2021
Board Observer Freenome2018 - 2021
Investor and Board Observer Genesis Therapeutics2018 - 2021
Investor Dyno Therapeutics2018 - 2021
Global Technology Group Investment Banking Morgan Stanley2017 - 2018
Department of Genetics and Synthetic Biology Harvard Medical School2013 - 2017
Discovery Oncology Genentech2015 - 2015
Associate Editor IEEE2013 - 2015
Medical Microfluidics Lab Researcher Rice University2011 - 2014
Nanotherapeutics and Drug Delivery Lab Researcher Rice University2010 - 2011